Premium
Re: First‐trimester risk assessment based on ultrasound and cell‐free DNA vs combined screening: a randomized controlled trial. K. O. Kagan, R. Sroka, J. Sonek, H. Abele, K. Lüthgens, M. Schmid, P. Wagner, S. Brucker, D. Wallwiener and M. Hoopmann. Ultrasound Obstet Gynecol 2018; 51: 437–444.
Author(s) -
Hui L.
Publication year - 2018
Publication title -
ultrasound in obstetrics and gynecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.202
H-Index - 141
eISSN - 1469-0705
pISSN - 0960-7692
DOI - 10.1002/uog.19027
Subject(s) - medicine , randomized controlled trial , ultrasound , cell free fetal dna , gynecology , first trimester , pregnancy , obstetrics , gestation , prenatal diagnosis , fetus , radiology , genetics , biology
Linked Comment: Ultrasound Obstet Gynecol 2018; 51: 437–444